- recruiting
Hepatitis C Inoculum Trial (HIT): Blood collection from hepatitis C positive donors for use in a controlled human challenge model
This study collects blood from people with Hepatitis C to help develop new vaccines. Your donated blood, containing the virus, will be used in future research where healthy volunteers are safely exposed and then cured, aiming to find better ways to prevent Hepatitis C.
United Kingdom · England - active not recruitingPHASE2
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection
This study is testing new medicines, Tobevibart and Elebsiran, against an existing treatment, Bulevirtide. It's for people in the UK who have long-lasting hepatitis delta virus (HDV) infection to see which treatment works best to control the virus and improve liver health.
Belgium · Bulgaria · France - active not recruitingPHASE3
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection
This study is testing new medicines, tobevibart and elebsiran, for people with chronic hepatitis D. It's a large study looking at how well they work and if they are safe, compared to starting treatment later.
United States · Canada · Georgia - active not recruitingPHASE3
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
This study is for people with chronic Hepatitis D (HDV) whose current medicine, bulevirtide, isn't fully controlling the virus. It will test if a new combination of medicines, tobevibart and elebsiran, works better. It's a key step in finding more effective treatments.
Austria · France · Germany